Skip to main content
Tessa NewsLink
Paste a health news link, or browse

Source study found

Story checked

Study defines early-onset cirrhosis caused by fatty liver disease (opens in a new tab)

news-medical.net · 2026-09-16

Short answerEvidenceSource

Short answer

Needs review

Study found.

We found the study, but the claim check did not finish.

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

We found the study behind this story.

We found the study, but couldn't compare the story to it: the study's evidence could not be profiled.

Open claim evidence
3

The source study

Risk Factors and Definition of Younger-Onset Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Cirrhosis

Clinical Gastroenterology and Hepatology · 2026
Open source record (opens in a new tab)
Then inspect each claim

Evidence layer

Claim by claim

The source study was found, but the study's evidence could not be profiled, so these claims couldn't be checked.

Claim 1 of 5Not checkedResearchers at University of California San Diego School of Medicine have published the first study to define early-onset cirrhosis caused by metabolic dysfunction-associated steatotic liver disease (MASLD), also known as fatty liver disease.View evidenceHide evidence

As statedfirst study

Not checked

The source study was found, but this claim couldn't be checked against it.

Claim 2 of 5Not checkedThe study, published in the September 16, 2026, online edition of Clinical Gastroenterology and Hepatology, found that people who develop cirrhosis before age 50 have a distinct risk profile shaped by inherited genetic factors and metabolic conditions, specifically type 2 diabetes.View evidenceHide evidence

As statedbefore the age of 50

Not checked

The source study was found, but this claim couldn't be checked against it.

Claim 3 of 5Not checkedUsing data from about 2,400 adults with biopsy-confirmed MASLD enrolled in the national NASH Clinical Research Network, investigators found that approximately 25% of cirrhosis cases occurred before age 50.View evidenceHide evidence

As statedabout 2,400 adults; approximately 25%

Not checked

The source study was found, but this claim couldn't be checked against it.

Claim 4 of 5Not checkedThe study defined this group as having 'early-onset MASLD cirrhosis' and reported that nearly one-third of participants with early-onset cirrhosis had scores that would not typically trigger further evaluation using standard screening thresholds.View evidenceHide evidence

As statednearly one-third

Not checked

The source study was found, but this claim couldn't be checked against it.

Claim 5 of 5Not checkedThe authors say younger adults with type 2 diabetes, obesity, or elevated genetic risk may benefit from more proactive liver assessment, and that earlier identification could support hepatocellular carcinoma surveillance and intervention.View evidenceHide evidence

Not checked

The source study was found, but this claim couldn't be checked against it.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Open the paper in Tessa

Risk Factors and Definition of Younger-Onset Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Cirrhosis

Clinical Gastroenterology and Hepatology · 2026

Source record (opens in a new tab)

Why this one

Near certain

NewsLink found the paper. Tessa is where you inspect it deeply.

Papers considered

The selected paper, plus nearby candidates.

Crossref, PubMed, Europe PMC · 32 candidate papers

Selected

Risk Factors and Definition of Younger-Onset Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Cirrhosis

Clinical Gastroenterology and Hepatology · 2026 · Crossref

Source (opens in a new tab)
Candidate

Cardiometabolic Risk Factors Impair Recompensation and Survival in Alcohol-associated Liver Disease.

Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association · 2026 · PubMed, Europe PMC

Tessa (opens in a new tab)Source (opens in a new tab)
Candidate

An Expert Consensus Delphi Panel in Metabolic Dysfunction- and Alcohol-associated Liver Disease: Opportunities and Challenges in Clinical Practice.

Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association · 2026 · PubMed

Tessa (opens in a new tab)Source (opens in a new tab)

And 26 more candidates considered.